Drug establishmentActive, Registered FY2026FDA warning letter on file
Sichuan Deebio Pharmaceutical Co.,Ltd
Sichuan Deebio Pharmaceutical Co.,Ltd is an FDA-registered drug establishment (FEI 3011139911) located in . The facility is active, registered for FY2026. Its most recent FDA inspection on record (2023-09-08) was classified OAI. FDA has issued 1 warning letter(s) to this facility.
FDA warning letter
A warning letter is FDA's formal notice of significant violations that require prompt correction. It can hold up product approvals, trigger import alerts, and put supply agreements at risk until the issues are resolved and FDA closes it out.
Establishment record
Inspection history
Questions
Is Sichuan Deebio Pharmaceutical Co.,Ltd registered with the FDA?
Yes. Sichuan Deebio Pharmaceutical Co.,Ltd is an FDA-registered drug establishment (FEI 3011139911) in . Its current registration status is Active, Registered FY2026.
Has Sichuan Deebio Pharmaceutical Co.,Ltd received an FDA warning letter?
Yes. FDA issued a warning letter to Sichuan Deebio Pharmaceutical Co.,Ltd; the most recent is dated Feb 5, 2024 (CGMP/Active Pharmaceutical Ingredient (API)/Adulterated).
What does Sichuan Deebio Pharmaceutical Co.,Ltd do?
Sichuan Deebio Pharmaceutical Co.,Ltd's FDA-registered operations are: Active pharmaceutical ingredient (API) manufacturing.
Related facilities
Source: FDA public data · status as of 2026-06-06